CA Stock MarketDetailed Quotes
MDP Medexus Pharmaceuticals Inc
- 1.600
- -0.020-1.23%
15min DelayMarket Closed May 17 16:00 ET
39.13MMarket Cap4.17P/E (TTM)
1.640High1.600Low2.73KVolume1.640Open1.620Pre Close4.43KTurnover3.53052wk High0.01%Turnover Ratio24.46MShares1.12052wk Low0.384EPS TTM35.40MFloat Cap11.250Historical High19.75P/E (Static)22.13MShs Float0.750Historical Low0.081EPS LYR2.47%Amplitude--Dividend TTM0.97P/B1Lot Size--Div YieldTTM
About Medexus Pharmaceuticals Inc Company
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company’s focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.
Company Profile
SymbolMDP
Company NameMedexus Pharmaceuticals Inc
Founded2013
MarketTSE
Employees98
Fiscal Year Ends03-31
Address35 Nixon Road Suite 1
CityBolton
CountryCAN
Zip CodeL7E 1K1
Phone+1 514 344-8765
Websitehttps://www.medexus.com
Company Executives
- Name
- Position
- Salary
- Kenneth d’Entremont
- Chief Executive Officer and Director
- --
- Marcel Konrad
- Chief Financial Officer
- --
- Mike Adelman
- General Manager, US Operations
- --
- Richard Labelle
- General Manager, Canadian Operations
- --
- Michael Mueller
- Chairman of the Board
- --
- Nancy Phelan
- Independent Director
- --
- Stephen Nelson
- Independent Director
- --
- Menassie Taddese, M.B.A.
- Independent Director
- --
- Benoit Gravel
- Independent Director
- --
- Dr. Harmony P. Garges, M.D.
- Independent Director
- --
- Ian C Wildgoose Brown
- General Counsel and Corporate Secretary
- --
Heat List
CA
Overall
Symbol
Latest Price
%Chg